Overview

Update
IPO / Stock
Went Public on Feb 6, 2014 / NASDAQ:EGLT
Total Equity Funding
$27.6M in 2 Rounds from 4 Investors
Headquarters:
Værløse
Description:
Egalet is a specialty pharmaceutical company developing pain management products.
Categories:
Biopharma, Health Care, Biotechnology
Website:
http://www.egalet.com
Social:

Company Details

Update

Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Funding Rounds (4) - $67.6M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2016$40M / Post Ipo Debt0
Feb, 2014undisclosed amount / Post Ipo Equity4
Mar, 2012undisclosed amount / Series B2
Apr, 2007$27.6M / Series B3

Current Team (6)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    Lejrvej 37-39

    Værløse, DK-3500

    DNK

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos